Antistax® in Patients With Chronic Venous Insufficiency

NCT02191280 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

260

Enrollment

INDUSTRY

Sponsor class

Conditions

Venous Insufficiency

Interventions

DRUG: Antistax®, low dose
DRUG: Antistax®, high dose
DRUG: Placebo

Sponsor

Boehringer Ingelheim